As Friday last (16th Oct) was officially the day Wyeth became Pfizer, we thought it presented the perfect opportunity to profile what is now one of Ireland’s largest employers. An internet search for Wyeth will bring you to the new Pfizer page (link).

Trinity Biotech plc is a public company (NASDAQ: TRIB) with manufacturing facilities in Bray, Ireland, Jamestown, New York and Carlsbad, California.
The company specialises in the development, manufacture and marketing of diagnostic products which utilise immunoassay technologies. Trinity markets over 120 products through distributors in 80 countries.

The company was formed in 1992 and attained its first full year of profit in 1997. Trinity Biotech has expanded through a combination of internal and acquisition-led growth.

Through a combination of in-house R & D and acquisitions, the company has assembled an impressive product portfolio and achieved an excellence in developing, manufacturing and marketing quality products that meet market demands. Its product range utilises immunoassay techniques, which have been employed to develop tests in five main formats. One-step rapid tests which utilise the company’s proprietary Uni-Gold™ Technology, multiple tests on Microtitre plates, Western Blot, immunofluorescence and coagulation